We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
AUM
$752M
AUM Growth
+$26.2M
Cap. Flow
-$6.76M
Cap. Flow %
-0.9%
Top 10 Hldgs %
43.11%
Holding
80
New
2
Increased
27
Reduced
31
Closed
4

Top Sells

Rank Stock Value
1
KMB icon
Kimberly-Clark
KMB
+$6.62M
2
FTV icon
Fortive
FTV
+$3.01M
3
ABMD
Abiomed Inc
ABMD
+$2.26M
4
GIS icon
General Mills
GIS
+$996K
5
UL icon
Unilever
UL
+$907K

Sector Composition

Rank Sector Weight
1 Healthcare 47.03%
2 Consumer Discretionary 12.27%
3 Industrials 10.47%
4 Technology 10.37%
5 Miscellaneous 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIF
1
DELISTED
Tiffany & Co.
TIF
$44.8M 5.95%
340,190
-2,146
-0.6% -$245K
NEOG icon
2
Neogen
NEOG
$2.58B
$36.6M 4.86%
912,060
-5,632
-0.6% -$208K
CGNX icon
3
Cognex
CGNX
$10.5B
$33.1M 4.4%
741,675
+2,275
+0.3% +$108K
IDXX icon
4
Idexx Laboratories
IDXX
$42.2B
$33M 4.38%
151,280
-1,950
-1% -$402K
ADI icon
5
Analog Devices
ADI
$176B
$31.9M 4.24%
332,845
+1,150
+0.3% +$109K
MA icon
6
Mastercard
MA
$507B
$30.6M 4.07%
155,666
+51
+0% +$9.59K
INGN icon
7
Inogen
INGN
$144M
$30.6M 4.06%
164,115
-3,800
-2% -$632K
ABMD
8
DELISTED
Abiomed Inc
ABMD
$30.2M 4.02%
73,940
-6,240
-8% -$2.26M
DXCM icon
9
DexCom
DXCM
$33.2B
$27.6M 3.66%
1,160,816
+1,500
+0.1% +$31.8K
PODD icon
10
Insulet
PODD
$10.2B
$26.1M 3.46%
304,165
+1,125
+0.4% +$101K
RTN
11
DELISTED
Raytheon Company
RTN
$25.9M 3.44%
134,139
+817
+0.6% +$172K
BF.B icon
12
Brown-Forman Class B
BF.B
$12.3B
$24.5M 3.26%
500,364
+20,828
+4% +$1.14M
DHR icon
13
Danaher
DHR
$146B
$24.3M 3.23%
278,053
-264
-0.1% -$23.5K
JNJ icon
14
Johnson & Johnson
JNJ
$663B
$23.9M 3.18%
197,245
+954
+0.5% +$119K
HON icon
15
Honeywell
HON
$66.4B
$22.9M 3.04%
175,950
+306
+0.2% +$40.7K
BIIB icon
16
Biogen
BIIB
$32.6B
$20.7M 2.75%
71,357
-870
-1% -$245K
NVO
17
Novo Nordisk
NVO
$206B
$18.8M 2.5%
814,890
+2,900
+0.4% +$68.9K
ROST icon
18
Ross Stores
ROST
$73.7B
$18.6M 2.48%
219,759
-1,224
-0.6% -$99.6K
SBUX icon
19
Starbucks
SBUX
$119B
$15.8M 2.1%
323,738
-7,635
-2% -$433K
HSIC icon
20
Henry Schein
HSIC
$10B
$14.5M 1.92%
253,933
+2,678
+1% +$151K
AMGN icon
21
Amgen
AMGN
$236B
$14.1M 1.88%
76,445
-579
-0.8% -$102K
NVRO
22
DELISTED
NEVRO CORP.
NVRO
$13.8M 1.84%
173,170
+4,365
+3% +$362K
MTD icon
23
Mettler-Toledo International
MTD
$27B
$13.5M 1.8%
23,350
+1,240
+6% +$707K
ABBV icon
24
AbbVie
ABBV
$453B
$11.5M 1.52%
123,700
-850
-0.7% -$83K
STT icon
25
State Street
STT
$53.4B
$10.8M 1.44%
116,308
+2,049
+2% +$203K

Similar funds

Tirschwell & Loewy's Q2 2018 Portfolio in Review

As of Q2 2018, Tirschwell & Loewy held 80 positions worth $752M, up 3.6% from $726M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Tirschwell & Loewy's Q2 2018 filing shows 2 new, 27 increased, 31 reduced and 4 closed positions. Its largest new stake was Meta Platforms (Facebook): 1,110 shares worth $216K. The largest sale was Kimberly-Clark, an estimated $6.62M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Tirschwell & Loewy's largest Q2 2018 buy was Meta Platforms (Facebook): 1,110 shares worth $216K.
  • Tirschwell & Loewy added most to Brown-Forman Class B in Q2 2018, an estimated $1.14M increase.
  • Tirschwell & Loewy's biggest Q2 2018 reduction was Fortive, cutting an estimated $3.01M.
  • Tirschwell & Loewy fully exited Kimberly-Clark in Q2 2018, selling an estimated $6.62M.
  • Tirschwell & Loewy's ten largest holdings make up 43% of its $752M portfolio in Q2 2018.
  • Tirschwell & Loewy opened 2 new positions and closed 4 in Q2 2018.
  • Tirschwell & Loewy's portfolio value rose 3.6% quarter-over-quarter to $752M.

Based on Tirschwell & Loewy's 13F filing for Q2 2018, filed 3 Aug 2018.